GSK Exercises Option to License Chemo...

GSK Exercises Option to License ChemoCentryx's CCR1 Inhibitor,...

There are 1 comment on the Sys-Con Media story from Jan 5, 2012, titled GSK Exercises Option to License ChemoCentryx's CCR1 Inhibitor,.... In it, Sys-Con Media reports that:

"This announcement is a key milestone for ChemoCentryx that further validates our ability to advance new medicines from drug discovery through clinical development," said , Ph.D., President and Chief Executive Officer of ChemoCentryx.A "Furthermore, the exercise fee associated with this agreement provides additional financial flexibility to our ... (more)

Join the discussion below, or Read more at Sys-Con Media.

Robson

Toronto, Canada

#1 May 6, 2012

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Arthritis Discussions

Title Updated Last By Comments
News Turmeric lowered high blood pressure (Feb '09) Fri dibyajyoti Saikia 42
News How to File A Complaint About DIRECTV (Jul '08) Thu Lisa wise ohio 242
News African-American patients with connective tissu... Feb 5 Spotted Girl 2
News Natural remedy reignites spark in bedroom (Feb '12) Jan 30 Delora 43
News Point woman shares orthopedic experience Jan 29 Happy momma 3
News Staying Intimate Later In Life (Aug '10) Jan 29 Britt 19
News U.S. FDA advisers back Pfizer arthritis drug (Aug '12) Jan 29 Claudio 13
More from around the web